25 Jan Insiders Were Right: BIIB Makes New 52-Week High
In trading on Tuesday, shares of Biogen Inc (Symbol: BIIB) touched a new 52-week high of $354.28/share. That’s a 45.03% rise, or $110 per share from the 52-week low of $244.28 set back on 05/31/2017. That means at today’s intraday high, any investor who purchased BIIB stock any time over the past 52 weeks has an unrealized gain, including company insiders.
Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, BIIB has seen 2 different instances of insiders buying over the trailing six month period.
|11/29/2017||Alexander J. Denner||Director||30,000||$317.36||$9,520,800.00|
|12/29/2017||Michel Vounatsos||Chief Executive Officer||780||$320.55||$250,029.00|
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.